Skip to main content

Transcend Wealth Collective, LLC

SEC CIK
0001776082
Latest filing
Aug 4, 2026

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overviewAll 13F holders of DNAFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q1 2022
Holdings of DNA by Transcend Wealth Collective, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−43,550−100.0%Sold outHolders
Q4 202243,550$73.6K<0.1%00.0%UnchangedHolders
Q3 202243,550$136.0K<0.1%00.0%UnchangedHolders
Q2 202243,550$104.0K<0.1%00.0%UnchangedHolders
Q1 202243,550$176.0K<0.1%+43,550NewHolders